DuPont de Nemours, Inc.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income From Continuing Operations $1.1b ($62.0m) ($96.0m) $98.0m
Net Income (Loss) Attributable to Parent $4.3b $1.5b $3.8b $498.0m ($3.0b) $6.5b $5.9b $423.0m $703.0m ($779.0m)
Net Income (Loss) Available to Common Stockholders, Basic $4.0b $1.4b $3.8b $497.0m ($3.0b) $6.5b $5.9b $423.0m $703.0m ($779.0m)
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $4.4b $1.6b $4.0b $600.0m ($2.9b) $6.5b $5.9b $462.0m $738.0m ($738.0m)
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $4.4b $1.7b $4.0b ($614.0m) ($2.9b) $1.8b $1.1b $533.0m $778.0m $98.0m
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $0 ($77.0m) ($5.0m) $1.2b $49.0m $4.7b $4.9b ($71.0m) ($40.0m) ($836.0m)
Net Income (Loss) Attributable to Noncontrolling Interest $86.0m $132.0m $155.0m $102.0m $28.0m $48.0m $49.0m $39.0m $35.0m $41.0m
Depreciation, Depletion and Amortization $2.9b $4.0b $5.9b $2.1b $3.1b $1.5b $1.2b $1.1b $1.2b $647.0m
Amortization of Intangible Assets $544.0m $1.0b $1.9b $1.1b $2.1b $725.0m $590.0m $600.0m $595.0m $291.0m
Depreciation $2.1b $2.8b $3.7b $1.0b $975.0m $670.0m $545.0m $547.0m $599.0m $356.0m
Depreciation Amortization Depletion $1.1b $580.0m $635.0m $647.0m
Deferred Income Tax Expense (Benefit) ($1.3b) ($2.1b) ($434.0m) ($478.0m) ($631.0m) ($290.0m) ($204.0m) ($364.0m) ($139.0m) $13.0m
Deferred Income Tax ($252.0m) ($157.0m) ($381.0m) ($163.0m)
Deferred Tax ($252.0m) ($157.0m) ($381.0m) ($163.0m)
Share-based Payment Arrangement, Noncash Expense $77.0m $38.0m
Payment, Tax Withholding, Share-based Payment Arrangement $65.0m $99.0m $128.0m $26.0m $27.0m $27.0m $27.0m $26.0m
Share-based Payment Arrangement, Expense $261.0m $392.0m $380.0m $106.0m $112.0m $76.0m $75.0m $74.0m $77.0m $38.0m
Equity Method Investment, Other than Temporary Impairment $456.0m $94.0m $10.0m
Goodwill, Impairment Loss $0 $1.5b $1.2b $3.2b $0 $0 $804.0m $0 $0
Restructuring Costs and Asset Impairment Charges $595.0m $3.3b $1.1b $588.0m $849.0m $57.0m $155.0m $146.0m $87.0m $151.0m
Asset Impairment Charge $0 $668.0m $0 $0
Equity Method Investment, Realized Gain (Loss) on Disposal $0
Gain (Loss) on Disposition of Assets $214.0m $1.2b $93.0m $5.1b $5.1b $19.0m $20.0m $3.0m
Gain (Loss) on Disposition of Business ($26.0m) $0 ($14.0m) $593.0m $143.0m $69.0m $9.0m
Gain (Loss) on Disposition of Other Assets $170.0m $198.0m $110.0m $157.0m $642.0m $171.0m $78.0m $19.0m $20.0m $3.0m
Gain (Loss) on Extinguishment of Debt $0 ($135.0m) $0 $0 ($74.0m) ($99.0m)
Income (Loss) from Equity Method Investments $442.0m $764.0m $1.0b $84.0m $191.0m $94.0m $75.0m $51.0m $60.0m ($7.0m)
Income Tax Expense (Benefit) $9.0m ($476.0m) $1.5b $140.0m ($23.0m) $392.0m $387.0m ($29.0m) $414.0m $102.0m
Operating Lease, Lease Income $58.0m $73.0m $75.0m $74.0m
Other Nonoperating Income (Expense) $152.0m $147.0m $215.0m
Earnings (Loss)es From Equity Investments $36.0m ($2.0m) $5.0m $8.0m
Income (Loss) from Equity Method Investments, Net of Dividends or Distributions ($243.0m) ($128.0m) ($83.0m) ($9.0m) ($59.0m) ($20.0m) ($13.0m) ($8.0m)
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Inventories $9.6b
Increase (Decrease) in Accounts Payable $569.0m $2.6b $201.0m $317.0m ($131.0m) ($310.0m) $77.0m $61.0m
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal $375.0m $1.0b ($19.0m) $0 $0
Environmental Remediation Expense $295.0m
Equity Securities, FV-NI, Unrealized Gain (Loss) $6.0m
Foreign Currency Transaction Gain (Loss), before Tax ($126.0m) ($63.0m) ($234.0m) ($110.0m) ($56.0m) ($53.0m) $15.0m ($73.0m) $3.0m ($34.0m)
Gain (Loss) Related to Litigation Settlement ($1.2b) ($332.0m)
Goodwill $15.3b $59.5b $59.0b $33.2b $30.2b $19.6b $16.7b $16.7b $16.6b $7.9b
Inventory Write-down $25.0m
Investment Income, Interest $107.0m $147.0m $210.0m $55.0m $10.0m $4.0m $50.0m $155.0m $73.0m $98.0m
Nonoperating Income (Expense) $1.5b $966.0m $592.0m $153.0m $675.0m $163.0m $191.0m $102.0m ($76.0m) $14.0m
Payments of Financing Costs $0 $555.0m
Beginning Cash Position $2.1b $3.8b $2.8b $1.9b
Cash Flow From Continuing Financing Activities ($7.6b) ($3.0b) ($1.8b) ($1.8b)
Cash Flow From Continuing Investing Activities $9.0b $481.0m ($562.0m) ($374.0m)
Cash Flow From Discontinued Operation ($763.0m) $698.0m $774.0m $421.0m
Cash From Discontinued Financing Activities $1.1b ($21.0m) $0
Cash From Discontinued Investing Activities ($103.0m) ($81.0m) ($33.0m)
Change In Account Payable ($138.0m) ($232.0m) ($36.0m) $61.0m
Change In Inventory ($215.0m) $117.0m $61.0m ($10.0m)
Change In Other Working Capital ($423.0m) ($255.0m) $117.0m ($163.0m)
Change In Payable ($138.0m) ($232.0m) ($36.0m) $61.0m
Change In Payables And Accrued Expense ($138.0m) ($232.0m) ($36.0m) $61.0m
Change In Receivables ($79.0m) $163.0m ($83.0m) ($201.0m)
Change In Working Capital ($855.0m) ($207.0m) $59.0m ($313.0m)
Changes In Cash $1.8b ($933.0m) ($849.0m) ($1.1b)
End Cash Position $3.8b $2.8b $1.9b $760.0m
Financing Cash Flow ($7.6b) ($3.0b) ($1.8b) ($1.8b)
Free Cash Flow $587.0m ($1.2b) $160.0m $172.0m
Gain Loss On Investment Securities $138.0m ($154.0m)
Gain Loss On Sale Of Business ($171.0m) ($78.0m) ($19.0m) ($20.0m)
Investing Cash Flow $9.0b $481.0m ($562.0m) ($374.0m)
Issuance Of Capital Stock $88.0m $27.0m $50.0m $32.0m
Net PPE Purchase And Sale $11.0b ($525.0m) ($320.0m) ($55.0m)
Operating Gains Losses ($40.0m) $10.0m $212.0m ($47.0m)
Other Non Cash Items $30.0m $107.0m ($9.0m) $124.0m
Pension And Employee Benefit Expense $2.0m $23.0m ($1.0m) $3.0m
Provisionand Write Offof Assets ($308.0m) ($92.0m) $13.0m
Purchase Of PPE $3.6b $3.8b $1.5b ($2.3b) $743.0m ($1.8b) ($320.0m) ($55.0m)
Repurchase Of Capital Stock ($4.4b) ($2.0b) ($500.0m) ($500.0m)
Sale Of PPE $797.0m $11.0b $1.2b $8.0m
Stock Based Compensation $75.0m $57.0m $56.0m $38.0m
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment ($3.0m) $4.0m $3.0m ($1.0m) $2.0m
Gain (Loss) on Derivative Instruments, Net, Pretax ($214.0m) ($208.0m) $104.0m
Other Operating Income (Expense), Net ($23.0m) $47.0m ($11.0m) $20.0m $10.0m $22.0m $25.0m
Net Cash Provided by (Used in) Operating Activities $5.6b $8.7b $4.7b $1.4b $4.1b $2.3b $588.0m $2.2b $2.3b $560.0m
Cash flows from investing activities:
Capital Expenditure ($662.0m) ($2.1b) ($605.0m) ($388.0m)
Capital Expenditure Reported ($662.0m) ($302.0m) ($285.0m) ($333.0m)
Payments to Acquire Businesses, Net of Cash Acquired $187.0m ($19.0m) $20.0m $180.0m $70.0m $2.3b ($5.0m) $1.8b $321.0m $55.0m
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net $2.4b $0 ($47.0m) $0 $0 $138.0m $31.0m
Net Investment Purchase And Sale ($1.3b) $1.3b $0 $0
Purchase Of Investment ($1.3b) ($32.0m) $0 $0
Gain (Loss) on Sale of Investments $0
Sale Of Investment $15.0m $1.3b $0 $0
Payments for (Proceeds from) Other Investing Activities $0 $100.0m ($28.0m) ($39.0m) ($12.0m) ($6.0m) ($43.0m) ($14.0m)
Net Other Investing Changes $12.0m $6.0m $43.0m $14.0m
Net Cash Provided by (Used in) Investing Activities ($3.5b) $4.3b ($2.5b) ($2.4b) $8.9b $172.0m ($849.0m) ($374.0m)
Cash flows from financing activities:
Issuance Of Debt $150.0m $600.0m $0 $0
Long Term Debt Issuance $1.2b $600.0m $0 $0
Net Issuance Payments Of Debt ($2.6b) ($300.0m) ($687.0m) ($4.1b)
Net Long Term Debt Issuance ($2.5b) ($300.0m) ($687.0m) ($4.1b)
Net Short Term Debt Issuance ($150.0m) $0 $0 $60.0m
Short Term Debt Issuance $150.0m $600.0m $0
Repayments of Long-term Debt $4.1b
Long Term Debt Payments ($3.1b) ($300.0m) ($687.0m) ($4.1b)
Repayment Of Debt ($3.1b) ($300.0m) ($687.0m) ($4.1b)
Short Term Debt Payments $0 ($750.0m) $0
Proceeds from Issuance of Common Stock $0 $66.0m $197.0m $85.0m $57.0m $115.0m $88.0m $27.0m $50.0m $32.0m
Common Stock Issuance $88.0m $27.0m $50.0m $32.0m
Net Common Stock Issuance ($4.3b) ($2.0b) ($450.0m) ($468.0m)
Payments for Repurchase of Common Stock $916.0m $1.0b $4.4b $750.0m $232.0m $2.1b
Payments of Ordinary Dividends, Common Stock $2.5b $3.4b $3.5b $1.6b $882.0m $630.0m $652.0m $651.0m $635.0m $597.0m
Common Stock Payments ($4.4b) ($2.0b) ($500.0m) ($500.0m)
Proceeds from Noncontrolling Interests $0 $0
Dividends Payable, Current $0
Cash Dividends Paid ($652.0m) ($651.0m) ($635.0m) ($597.0m)
Common Stock Dividend Paid ($652.0m) ($651.0m) ($635.0m) ($597.0m)
Proceeds from (Payments for) Other Financing Activities ($2.0m) ($1.0m) $6.0m ($29.0m) ($4.0m) ($1.0m) ($1.0m) ($4.0m)
Net Other Financing Charges ($57.0m) ($32.0m) ($54.0m) $3.4b
Net Cash Provided by (Used in) Financing Activities ($4.0b) ($6.5b) ($1.9b) ($6.5b) ($7.7b) ($3.0b) ($1.8b) ($1.8b)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents ($77.0m) $297.0m ($344.0m) $9.0m $67.0m ($72.0m) ($148.0m) ($37.0m) ($62.0m) $11.0m
Effect Of Exchange Rate Changes ($148.0m) ($36.0m) ($62.0m) $11.0m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect ($77.0m) $297.0m $7.0m $9.0m $67.0m ($6.7b) $1.7b ($969.0m) ($911.0m) ($1.1b)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents ($77.0m) $297.0m $14.0b $1.6b $8.8b $2.1b $3.8b $2.8b $1.9b $757.0m
Supplemental disclosure of cash flow information:
Change In Cash Supplemental As Reported $1.7b ($968.0m) ($911.0m) ($1.1b)
Interest Paid, Excluding Capitalized Interest, Operating Activities $1.2b $1.3b $2.1b $969.0m $647.0m $498.0m $494.0m $408.0m $394.0m $362.0m
Income Taxes Paid, Net $1.6b $1.4b $2.2b $722.0m $495.0m $561.0m $829.0m ($27.0m) ($27.0m) $127.0m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.